Purchase Order 36C24E21P0047
- Not listed
- This is a $29,452.50 firm fixed price delivery order contract awarded to Illumina, Inc. by the Plains Area agency, a civilian federal agency, for the ISCAN SILVER SUPPORT PLAN. The contract does not have a set-aside designation. Illumina, a leading manufacturer and provider of genetic sequencing and genomic analysis technologies, is providing a range of sequencing platforms, reagents, consumables, maintenance services, and technical support to support the agency's scientific research,...
- This is a firm fixed-price purchase order contract awarded by the Plains Area division of a civilian federal agency to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $27,048.00, is for an ISCAN Service Agreement with a period of performance through August 17, 2019. Illumina, headquartered in San Diego, California, provides a wide range of genomic sequencing platforms, reagents, and bioinformatics software to numerous...
- This is a firm fixed price purchase order contract awarded by the Plains Area agency of the U.S. government to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $27,853.00, is for an ISCAN SILVER SUPPORT PLAN with an ultimate completion date of August 17, 2020. The contract does not have a set-aside designation. Illumina is a for-profit organization and manufacturer of goods that specializes in developing and providing...
- This is a firm fixed price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Illumina, Inc. for an ISCAN BRONZE SUPPORT PLAN with a ceiling value of $93,567.00. The award has an ultimate completion date of April 4, 2025 and does not utilize a set-aside. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, has previously provided various sequencing instruments, reagents, and services to support...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
- This is a firm fixed-price delivery order awarded by the Northeast Area division of a civilian federal agency to Illumina, Inc. under a broader service agreement contract for the "ISCAN BRONZE SUPPORT PLAN" valued at $16,891.72. The award has a period of performance through May 21, 2024. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, including various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and...
- This is a federal purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents, to provide DNA sequencing equipment maintenance services. The contract has a firm fixed price of $100,240.75 and a completion date of November 26, 2023. The contract is not set aside for any specific business category. Illumina has previously been awarded other federal contracts and subcontracts by agencies such as the...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for a preventive service contract. The contract has a ceiling value of $14,514.00 and a performance period running through January 26, 2026. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously been awarded other federal contracts and subcontracts to provide sequencing systems, reagents, and related services...
- This firm fixed-price delivery order was awarded by the Northeast Area Division of a civilian federal agency to Illumina, Inc., a leading provider of genetic sequencing technologies and services. The $24,752.43 contract is for the purchase of supplies used to operate Illumina's sequencing instruments, which will be used to sequence DNA samples. The contract has a period of performance through May 2025 and does not utilize any set-aside designations. Illumina holds multiple Indefinite Delivery...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 23 to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $179,000.00 contract provides for an ILLUMINA NEXSEQ 2000 SERVICE CONTRACT with a period of performance through October 2, 2029. This contract does not utilize any set-aside designations. The award represents a continuation of Illumina's...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract, valued at $174,779.55, is for an ISCAN Silver Support Plan that will provide maintenance and support services for Illumina's sequencing systems over a base year and four option years, with a final completion date of February 3, 2026. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Agriculture (USDA), to supply a range of sequencing instruments, reagents, and related services. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $31.9k | 1/31/25 | |
| P00005 | Other Administrative Action | ($2k) | 2/21/24 | |
| P00004 | Exercise an Option | $30.7k | 1/23/24 | |
| P00003 | Exercise an Option | $29.5k | 1/19/23 | |
| P00002 | Exercise an Option | $28.4k | 12/21/21 |